View Document Preview and Link Open Document File Size: 1,13 MB Share Result on Facebook
Company ACC/AHA HF / VF / Primary Endpoint HF / Medtronic Inc. / / Continent Europe / / Country Turkey / United States / Canada / Australia / / Currency pence / / Event FDA Phase / / Facility Hall Walk / RAFT Study Overview The University of Ottawa Heart Institute / / IndustryTerm Treatment of Chronic Heart Failure / / MedicalCondition Mildly Symptomatic Patients Heart failure / tachyarrhythmia / vEntricular dysfunction / disease / Chronic Heart Failure / serious cardiac disease / chronic / left bundle branch block / sudden cardiac arrest / heart failure / Mildly Symptomatic Heart Failure / left bundle branch block morphology / / MedicalTreatment Cardiac Resynchronization Therapy / CCR / / Organization Data Monitoring Committee / New York Heart Association / Adverse Event Advisory Committee / FDA / Executive Committee / University of Ottawa / Adjudication Committee / Data and Safety Monitoring Board / / Product RAFT Additional Cardiovascular Medication / REVERSE Additional Cardiovascular Medication / P010031 / / Region Western Europe / / SocialTag 
Base SubmissionTemplate_R00